PepsiCo's Lay's is the most exposed food brand, with Doritos, Hershey's, Cheetos, Kellogg's and Reese's also vulnerable, Brand Finance determined.
* The world's 100 most valuable food brands face a $73 billion risk from an uptick in consumers using GLP-1 drugs to lose weight, according to a report from Brand Finance, a brand valuation consultancy firm.
* Top food brands make up $278 billion in value, and roughly a quarter of that is at risk from the effect of GLP-1s, the report said.
* Lay's is the most exposed food brand to the phenomenon globally, with the report finding $6.8 billion of its $15.1 billion brand value at risk. PepsiCo's five major snack brands collectively have $14.1 billion in exposure, the consultancy firm determined.
Dive Insight:
Around 11% of U.S. adults currently take appetite-suppressing GLP-1 medications for weight loss, according to a Gallup update in September, close to quadrupling from 3% in 2024. With 137 million Americans — or more than half of all adults — eligible for the drug, the market for these medications is expected to skyrocket.
This could have major implications for major food companies, many of them snack manufacturers. In households ...